Literature DB >> 22394392

Adrenergic stimulation-released 5-HT stored in adrenergic nerves inhibits CGRPergic nerve-mediated vasodilatation in rat mesenteric resistance arteries.

Hirohito Fujii1, Shingo Takatori, Yoshito Zamami, Narumi Hashikawa-Hobara, Natsuki Miyake, Panot Tangsucharit, Mitsunobu Mio, Hiromu Kawasaki.   

Abstract

BACKGROUND AND
PURPOSE: 5-HT is taken up by and stored in adrenergic nerves and periarterial nerve stimulation (PNS) releases 5-HT to cause vasoconstriction in rat mesenteric arteries. The present study investigated whether PNS-released 5-HT stored in adrenergic nerves affects the function of perivascular calcitonin gene-related peptide-containing (CGRPergic) nerves. EXPERIMENTAL APPROACH: Rat mesenteric vascular beds without endothelium and with active tone were perfused with Krebs solution. Changes in perfusion pressure in response to PNS and CGRP injection were measured before (control) and after perfusion of Krebs solution containing 5-HT (10 µM) for 20 min. Distributions of 5-HT- and TH-immunopositive fibres in mesenteric arteries were studied using immunohistochemical methods. KEY
RESULTS: PNS (1-4 Hz) frequency dependently caused adrenergic nerve-mediated vasoconstriction followed by CGRPergic nerve-mediated vasodilatation. 5-HT treatment inhibited PNS-induced vasodilatation without affecting exogenous CGRP-induced vasodilatation, while it augmented PNS-induced vasoconstriction. Guanethidine (adrenergic neuron blocker), methysergide (non-selective 5-HT receptor antagonist) and BRL15572 (selective 5-HT1D receptor antagonist) abolished inhibition of PNS-induced vasodilatation in 5-HT-treated preparations. Combined treatment with 5-HT and desipramine (catecholamine transporter inhibitor), but not fluoxetine (selective 5-HT reuptake inhibitor), did not inhibit PNS-induced vasodilatation. Exogenous 5-HT inhibited PNS-induced vasodilatation, which was antagonized by methysergide. In immunohistochemical experiments, 5-HT-immunopositive nerves, colocalized with adrenergic TH-immunopositive nerves, were observed only in 5-HT-treated mesenteric arteries, but not in control preparations or arteries co-treated with desipramine. CONCLUSIONS AND IMPLICATIONS: These results suggest that 5-HT can be taken up by and released from adrenergic nerves in vitro by PNS to inhibit CGRPergic nerve transmission in rat mesenteric arteries.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394392      PMCID: PMC3402773          DOI: 10.1111/j.1476-5381.2012.01935.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries.

Authors:  M Urabe; H Kawasaki; K Takasaki
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat.

Authors:  H Kawasaki; K Takasaki; A Saito; K Goto
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

4.  Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat.

Authors:  H Kawasaki; A Saito; K Takasaki
Journal:  Circ Res       Date:  1990-09       Impact factor: 17.367

5.  Pharmacological characterization of presynaptic alpha-adrenoceptors in the modulation of the 5-hydroxytryptamine release from vascular adrenergic nerves in the rat.

Authors:  H Kawasaki; K Takasaki
Journal:  Jpn J Pharmacol       Date:  1986-12

Review 6.  Serotonin and migraine: a reconsideration of the central theory.

Authors:  Alessandro Panconesi
Journal:  J Headache Pain       Date:  2008-07-31       Impact factor: 7.277

7.  Calcitonin gene-related peptide mediates acetylcholine-induced endothelium-independent vasodilation in mesenteric resistance blood vessels of the rat.

Authors:  M Takenaga; H Kawasaki; A Wada; T Eto
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

8.  Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin.

Authors:  Nicole M E Carmichael; Milton P Charlton; Jonathan O Dostrovsky
Journal:  Pain       Date:  2007-05-17       Impact factor: 6.961

9.  NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries.

Authors:  H Kawasaki; C Nuki; A Saito; K Takasaki
Journal:  Am J Physiol       Date:  1991-09

10.  Proton acts as a neurotransmitter for nicotine-induced adrenergic and calcitonin gene-related peptide-containing nerve-mediated vasodilation in the rat mesenteric artery.

Authors:  Hiromu Kawasaki; Shinji Eguchi; Satoko Miyashita; Shu Chan; Kazuhiro Hirai; Narumi Hobara; Ayako Yokomizo; Hidetoshi Fujiwara; Yoshito Zamami; Toshihiro Koyama; Xin Jin; Yoshihisa Kitamura
Journal:  J Pharmacol Exp Ther       Date:  2009-05-29       Impact factor: 4.030

View more
  2 in total

1.  Fluoxetine and Raynaud's phenomenon: friend or foe?

Authors:  Charles Khouri; Thomas Gailland; Marion Lepelley; Matthieu Roustit; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2017-06-04       Impact factor: 4.335

Review 2.  Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.

Authors:  Abimael González-Hernández; Bruno A Marichal-Cancino; Jair Lozano-Cuenca; Jorge S López-Canales; Enriqueta Muñoz-Islas; Martha B Ramírez-Rosas; Carlos M Villalón
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.